<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="59663">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02329275</url>
  </required_header>
  <id_info>
    <org_study_id>Lab.Reprod.Biol.- Odense.02</org_study_id>
    <nct_id>NCT02329275</nct_id>
  </id_info>
  <brief_title>HPV as a Possible Cause of Azoospermia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Azoospermia is found in 5-20% of all men suffering from infertility, and in more than 20%
      azoospermia remains unexplained. The investigators suggest, that HPV may be an etiological
      factor in azoospermia and reduced sperm production.

      The investigators plan to examine the occurrence of HPV in testicular tissue from 100
      azoospermic men and to compare with the HPV occurrence in testicular tissue from a control
      group of 40 normal, healthy men undergoing vasectomy. Since HPV, in a recent Danish study,
      was detected on sperm in 16% of 188 randomly selected semen donors, the investigators also
      plan to examine the occurrence of HPV on sperm ejaculated during the last week before
      vasectomy. If HPV should be found in testicular tissue from men belonging to the control
      group, it will be highly relevant to compare with the HPV occurrence on sperm ejaculated
      from the men in concern.

      A Linear Array HPV Genotyping Kit from Roche will be used for detection of HPV in testicular
      tissue and ejaculates. In total, with this test kit 37 HPV genotypes are examined for,
      including 13 high risk types.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HPV DNA in testicular tissue</measure>
    <time_frame>Two years</time_frame>
    <description>In tissue from both azoospermic and proven fertile men</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HPV DNA in ejaculates</measure>
    <time_frame>Two years</time_frame>
    <description>In ejaculates from the proven fertile men</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">140</enrollment>
  <condition>HPV in Testis Tissue</condition>
  <arm_group>
    <arm_group_label>Azoospermic men</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Men with proven fertility</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Testicular biopsy</intervention_name>
    <arm_group_label>Azoospermic men</arm_group_label>
    <arm_group_label>Men with proven fertility</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Group 1: Unselected azoospermic men referred to the fertility clinic Group 2: Proven
        fertile men referred for vasectomy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men with azoospermia (Group 1) and proven fertile men undergoing vasectomy (Group 2)

        Exclusion Criteria:

          -  Men with testicular abnormalities (Group 2)

          -  Men who do not understand the purpose and possible consequences of the study (both
             groups)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jens Fedder, MD, PhD</last_name>
    <phone>+45 26820368</phone>
    <email>fedder@dadlnet.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fertility Clinic, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens Fedder, MD, PhD</last_name>
      <phone>+45 268 20 368</phone>
      <email>fedder@dadlnet.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 3, 2016</lastchanged_date>
  <firstreceived_date>December 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Jens Fedder</investigator_full_name>
    <investigator_title>Professor, Consultant, Ph.D.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
